Search

everythinglearnresearchcommunity

for

Search:↓

Patients should discuss complementary medicine use with doctors to improve health outcomes.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

Finasteride does not prevent bladder cancer.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

A group has developed therapies that show promise for treating cancer and various other conditions.

High TSPEAR levels in colorectal cancer predict worse outcomes.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Women and men experience different quality of life and symptom distress after kidney transplant with immunosuppressive therapy.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

International medical graduates scored higher than U.S. graduates on a medical exam.

Applying the anti-cancer drug Bortezomib to skin can promote hair growth and increase hair proteins through the GATA-3 factor.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

REV7 is crucial for genome stability and cancer treatment, making it a potential target for therapy.

Vitamin D may help regulate cholesterol and influence prostate cancer development.

Ayurveda-based care may improve quality of life for breast cancer patients without serious side effects.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Using ultrasound may make cisplatin more effective against cervical cancer in mice.

Nanozymes show promise for effective and safe cancer treatment.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.